SEQENS
Founded Year
2003Stage
Acq - Fin - IV | AliveRevenue
$0000About SEQENS
SEQENS specializes in pharmaceutical synthesis and specialty ingredients. It develops tailor-made solutions and ingredients for various industries, including healthcare, electronics, cosmetics, food, and home care. The company was founded in 2003 and is based in Ecully, France.
Missing: SEQENS's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: SEQENS's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Latest SEQENS News
Feb 1, 2023
Location serves as the US flagship for company’s global pharma development network.
SEQENS Frequently Asked Questions (FAQ)
When was SEQENS founded?
SEQENS was founded in 2003.
Where is SEQENS's headquarters?
SEQENS's headquarters is located at 21, Chemin de la Sauvegarde, Ecully.
What is SEQENS's latest funding round?
SEQENS's latest funding round is Acq - Fin - IV.
Who are the investors of SEQENS?
Investors of SEQENS include SK Capital Partners, Merieux Developpement, Eurazeo, Ardian and Bain Capital.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.